You are here: Industry Insights > myocardial infarction

News List

Cannabis Use Disorder May Up Risk of Perioperative Heart Attack drugs
December 19, 2019
Active cannabis use disorder is associated with an increased perioperative risk of myocardial infarction, according to a study published in the December issue of Anesthesiology.
TSI Reports Enrollment of First 10 Patients in its Phase 2 Ischemic Stroke Clinical Trial and Completion of its Phase 2 Study Protocol in Myocardial Infarction b3cnewswire
October 31, 2019
Thrombolytic Science, LLC (TSI) announced progress with 10 patients enrolled in its prospective, randomized, multicenter Phase 2 clinical trial, designed to confirm the safety and ...
ACC: Long-Term Outcomes for MI Similar at ≤40, 40 to 50 drugs
March 08, 2019
Patients with myocardial infarction (MI) at age 40 years or younger have similar long-term all-cause and cardiovascular death rates as patients aged older than 40 years, according to a study presented at the annual meeting of the American College of Cardi
Concerns over Brexit cause Recardio to cease clinical trials in the UK pharmaceutical
November 19, 2018
California-based clinical stage pharmaceutical company Recardio has halted its UK activities due to concerns over Brexit and how it will impact the approval of medicines.
AstraZeneca-backed studies reveal constant risk of CV events and death pharmaceutical
August 30, 2018
Findings from three real-world evidence clinical studies supported by AstraZeneca have indicated the need for better secondary prevention of long-term ischemic risk in people who have survived a heart attack.